Details for Australian Trade Mark No. 1203580 (hide)

Owner Arena Pharmaceuticals, Inc.

Convention US 24 January 2007 77089729

Various Convention priority claimed: 24 January 2007, United States of America, No. 77089729 in respect of PHARMACEUTICAL PREPARATIONS AND COMPOUNDS; PHARMACEUTICAL PREPARATIONS AND COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS, DISORDERS OF THE CENTRAL NERV

Filing Date 2 July 2007

Classes

Class 5 Pharmaceutical preparations and compounds; pharmaceutical preparations and compounds for the treatment of metabolic disorders, disorders of the central nervous system, cardiovascular disorders, and inflammatory and auto immunity disorders

Class 42 Scientific and technological services, namely medical laboratories; scientific research, studies, and development for others in the field of pharmaceuticals; scientific research and development for others, namely pharmaceutical discovery, pharmaceutical screening assay development and studies, structure activity relationship studies, process development relating to synthesis and scalability for active pharmaceutical ingredients, large scale synthesis of active pharmaceutical ingredients, and formulation development; conducting and evaluating clinical trials

Event Publications

15 November 2007 Application Accepted

13 March 2008 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1203581-ANTYPIROGEL

1203579